Abstract:Pharmaceutical evaluations of nanomedicines are of great significance for their further launch into industry and clinic. Near-infrared (NIR) fluorescence imaging plays essential roles in preclinical drug development by providing important insights into the biodistributions of drugs in vivo with deep tissue penetration and high spatiotemporal resolution. However, NIR-II fluorescence imaging has rarely been exploited for in vivo real-time pharmaceutical evaluations of nanomedicine. Herein, we developed a highly emissive NIR-II luminophore to establish a versatile nanoplatform to noninvasively monitor the in vivo metabolism of nanomedicines bound various polyethylene glycol (PEG) ligands in a real-time manner. An alternative D–A–D conjugated oligomer (DTTB) was synthesized to achieve NIR-II emission peaked at ∼1050 nm with high fluorescence QYs of 13.4% and a large absorption coefficient. By anchoring with the DTTB molecule, intrinsically fluorescent micelles were fabricated and bound with PEG ligands at various chain lengths. In vivo NIR-II fluorescence and photoacoustic imaging results revealed that an appropriate PEG chain length could effectively contribute to the longer blood circulation and better tumor targeting. In vivo therapeutic experiments also confirmed the optimized nanomedicines have efficient photothermal elimination of tumors and good biosafety. This work offered an alternative highly fluorescent NIR-II material and demonstrated a promising approach for real-time pharmaceutical evaluation of nanomedicine in vivo.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsnano.0c05885?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsnano.0c05885</a>.Additional experimental methods, the synthetic route to DTTB, NMR spectra of DTTB, HRMS spectra of DTTB, UV–vis–NIR spectra and emission spectra of DTTB, TEM image of and NMs, PA imaging stability test of ICG and solution, ex vivo NIR-II fluorescence imaging of major organs, photothermal properties tests of , photothermal ablation efficiency assessment of in vitro, and hemolysis analysis of (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c05885/suppl_file/nn0c05885_si_001.pdf">PDF</a>)Real-time whole-body NIR-II fluorescence imaging video of the mice within 60 s after the intravenous injection of NMs (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c05885/suppl_file/nn0c05885_si_002.avi">AVI</a>)Real-time whole-body NIR-II fluorescence imaging video of the mice within 60 s after the intravenous injection of NMs (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c05885/suppl_file/nn0c05885_si_003.avi">AVI</a>)Real-time whole-body NIR-II fluorescence imaging video of the mice within 60 s after the intravenous injection of NMs (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c05885/suppl_file/nn0c05885_si_004.avi">AVI</a>)This article has not yet been cited by other publications.

Promoted NIR‐II Fluorescence by Heteroatom‐Inserted Rigid‐Planar Cores for Monitoring Cell Therapy of Acute Lung Injury (Small 1/2022)

Promoted NIR‐II Fluorescence by Heteroatom‐Inserted Rigid‐Planar Cores for Monitoring Cell Therapy of Acute Lung Injury

A high‐performance cell‐labeling NIR‐II dye for in vivo cell tracking

Differential Responses of Transplanted Stem Cells to Diseased Environment Unveiled by a Molecular NIR-II Cell Tracker

Inhaled NIR‐II Nanocatalysts for Real‐Time Monitoring and Immunomodulatory Therapy of Acute Lung Injury

In Vivo Tracking of Cell Viability for Adoptive Natural Killer Cell‐Based Immunotherapy by Ratiometric NIR‐II Fluorescence Imaging

Noninvasively real-time monitoring in-vivo immune cell and tumor cell interaction by NIR-II nanosensor

Recent Advances in Tracking the Transplanted Stem Cells Using Near-Infrared Fluorescent Nanoprobes: Turning from the First to the Second Near-Infrared Window

NIR-II Fluorescence Lymphatic Imaging and Intraoperative Navigation Based on the “isolated Cage” Monodisperse Strategy

Efficient and stable NIR‐II phosphorescence of metallophilicmolecular oligomers for in vivo single‐cell tracking and time‐resolved imaging

Amplification of Near-Infrared Fluorescence in Semiconducting Polymer Nanoprobe for Grasping the Behaviors of Systemically Administered Endothelial Cells in Ischemia Treatment

NIRII-HDs: A Versatile Platform for Developing Activatable NIR-II Fluorogenic Probes for Reliable In Vivo Analyte Sensing

Organic Semiconducting Polymer Nanoparticles for Photoacoustic Labeling and Tracking of Stem Cells in the Second Near-Infrared Window.

Efficient and Stable NIR-II Phosphorescence of Metallophilic Molecular Oligomers for in Vivo Single-Cell Tracking and Time-Resolved Imaging

NIR-II Fluorescent Biodegradable Nanoprobes for Precise Acute Kidney/Liver Injury Imaging and Therapy.

Single-Molecular Near-Infrared-II Theranostic Systems: Ultrastable Aggregation-Induced Emission Nanoparticles for Long-Term Tracing and Efficient Photothermal Therapy (vol 12, pg 11282, 2018)

In Vivo Real-Time Pharmaceutical Evaluations of Near-Infrared II Fluorescent Nanomedicine Bound Polyethylene Glycol Ligands for Tumor Photothermal Ablation

NIR-II organic small molecule probe for labeling lymph nodes and guiding tumor imaging

Labeling Stem Cells with A Near-Infrared Fluorescent Heptamethine Dye for Noninvasive Optical Tracking

An organic NIR-II nanofluorophore with aggregation-induced emission characteristics for in vivo fluorescence imaging

NIR-II Dyad-Doped Ratiometric Nanosensor with Enhanced Spectral Fidelity in Biological Media for in Vivo Biosensing